You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry

Citation Tools

Article menu

Download PDFPDF

Psoriatic arthritis
Original research
Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Correll CK, Stryker S, Collier D On behalf of the CARRA Registry Investigators, et al
Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry
RMD Open 2023;9:e002943. doi: 10.1136/rmdopen-2022-002943